Quantcast

Latest Pharmaceutical sciences Stories

2014-09-16 12:30:26

BOSTON, September 16, 2014 /PRNewswire/ -- Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. These trends, however, were affected by recent developments connected with the political situation and the following political and economic sanctions imposed on Russia. (Logo:...

2014-09-16 08:30:30

"PIM" Designation For DCVax-L Is First Step In 2-Step Process for Early Access Approval BETHESDA, Md., Sept. 16, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that its DCVax-L is the first product to receive formal designation as a "Promising Innovative Medicine" (PIM) under the new "Early Access to Medicines Scheme" (EAMS) launched in the UK...

2014-09-16 08:29:41

Clinical Trials Mark Important Milestone in Development of Two Highly Complex Products PITTSBURGH, Sept. 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, today announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's Advair Diskus® and its insulin analog to Sanofi's Lantus®. http://photos.prnewswire.com/prnvar/20140423/77793 In October 2014, Mylan will commence a Phase III...

2014-09-16 08:27:31

LOS ANGELES, Sept. 16, 2014 /PRNewswire/ -- The National Marijuana News ("TNMNews") will air a new episode today featuring interviews with Congressman Dr. Andy Harris (R-MD), and Meiko Hester-Perez, founder of the Unconventional Foundation for Autism, on their website at www.TheNationalMarijuanaNews.com and Internet radio station Live365. http://photos.prnewswire.com/prnvar/20140916/146355 Dr. Andy Harris (R-MD)Dr. Harris defends why he voted against a House Appropriations bill...

2014-09-15 23:10:01

On September 9, the FDA announced that it requested the recall of sterile drug products by Downing Labs (aka NuVision Pharmacy) due to lack of sterility. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) September 15, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on sterile drug products. Following a...

2014-09-15 23:03:17

ComplianceOnline, the leading GRC advisory network, and regulatory affairs expert, Dr. Mukesh Kumar will conduct a two day seminar on requirements of SOPs for FDA-regulated industries. Durham, North Carolina (PRWEB) September 15, 2014 ComplianceOnline, the leading governance, risk and compliance advisory network with over 500 experts in various regulatory subjects, today announced a seminar on SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations. The two day...

2014-09-15 16:29:14

Patients starting on generic statins vs. branded statins had an eight percent lower rate of cardiovascular events and death WOONSOCKET, R.I., Sept. 15, 2014 /PRNewswire/ -- A new study by researchers at CVS Health (NYSE: CVS) and Brigham and Women's Hospital published today in the Annals of Internal Medicine, is the first to investigate whether starting on a generic versus a brand-name drug for the treatment of high cholesterol is associated with improved health outcomes. The...

2014-09-15 16:29:09

SAN DIEGO, Sept. 15, 2014 /PRNewswire/ -- Cannalink, Inc. (OTC Pink Sheets: SUPID) (the "Company"), formerly Superwire, Inc., announces that it has effected a change of name of the Company from Superwire, Inc. to Cannalink, Inc. and a 1 for 50 reverse split. The two corporate actions were approved by FINRA effective September 10, 2014. The Company maintains its headquarters in San Diego, California and is managed by its new Chairman and Chief Executive Officer, Robert L. Plomgren....

2014-09-15 08:29:58

PLYMOUTH MEETING, Pa., Sept. 15, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has met the stringent listing criteria for the NASDAQ Global Select Market and effective today has transferred to this U.S. stock exchange from the NYSE MKT. The company will continue to trade under its current ticker symbol, "INO." NASDAQ Global Select Market, a segment of the NASDAQ Global Market, maintains the highest initial listing standards of any exchange...

2014-09-15 08:29:50

SPRINGFIELD, N.J., Sept. 15, 2014 /PRNewswire/ -- Hudson Robotics, Inc., of Springfield, NJ, in cooperation with Johns Hopkins University, has recently been awarded an NIH grant to develop a commercially viable high-throughput screening (HTS) system for in vivo studies of zebrafish. Logo - http://photos.prnewswire.com/prnh/20140912/145910 This system, termed the Automated Reporter Quantification in vivo (ARQiv) system, will bring high-throughput screening technology into the realm...


Latest Pharmaceutical sciences Reference Libraries

Phytotherapy Research
2012-05-01 10:17:25

Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Topics include pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Short communications dealing with the pharmacology and screening...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'